We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$46.3B
AUM Growth
+$3.2B
Cap. Flow
+$2.34B
Cap. Flow %
5.07%
Top 10 Hldgs %
17.9%
Holding
3,541
New
248
Increased
1,836
Reduced
1,143
Closed
207

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Healthcare 9.23%
3 Financials 8.81%
4 Industrials 6.85%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDOG icon
1251
ALPS International Sector Dividend Dogs ETF
IDOG
$553M
$3.33M 0.01%
125,887
+42,960
+52% +$1.13M
X
1252
DELISTED
US Steel
X
$3.33M 0.01%
150,453
+96,463
+179% +$2.29M
RRC icon
1253
Range Resources
RRC
$9.01B
$3.33M 0.01%
143,509
+50,164
+54% +$1.26M
SDIV icon
1254
Global X SuperDividend ETF
SDIV
$1.21B
$3.32M 0.01%
51,084
+13,661
+37% +$879K
KBWB icon
1255
Invesco KBW Bank ETF
KBWB
$6.98B
$3.31M 0.01%
67,168
-122,567
-65% -$5.8M
FNY icon
1256
First Trust Mid Cap Growth AlphaDEX Fund
FNY
$599M
$3.31M 0.01%
95,771
+6,568
+7% +$223K
BCR
1257
DELISTED
CR Bard Inc.
BCR
$3.31M 0.01%
10,466
-23,478
-69% -$6.97M
ABM icon
1258
ABM Industries
ABM
$2.86B
$3.3M 0.01%
79,433
+1,705
+2% +$72.4K
BV
1259
DELISTED
Bazaarvoice, Inc.
BV
$3.29M 0.01%
665,715
+6,375
+1% +$29.4K
SGRY icon
1260
Surgery Partners
SGRY
$2.03B
$3.29M 0.01%
144,421
-10,612
-7% -$218K
STIP icon
1261
iShares 0-5 Year TIPS Bond ETF
STIP
$15.8B
$3.29M 0.01%
32,738
+12,847
+65% +$1.3M
JHML icon
1262
John Hancock Multifactor Large Cap ETF
JHML
$1.2B
$3.28M 0.01%
103,634
+86,951
+521% +$2.72M
EXAS
1263
DELISTED
Exact Sciences
EXAS
$3.26M 0.01%
92,072
-9,725
-10% -$300K
WTPI
1264
WisdomTree Equity Premium Income Fund
WTPI
$501M
$3.23M 0.01%
111,434
+4,946
+5% +$142K
CNQ icon
1265
Canadian Natural Resources
CNQ
$94.8B
$3.23M 0.01%
228,383
-45,570
-17% -$686K
NUVA
1266
DELISTED
NuVasive, Inc.
NUVA
$3.23M 0.01%
41,963
-7,206
-15% -$539K
LNG icon
1267
Cheniere Energy
LNG
$53.6B
$3.22M 0.01%
66,161
-2,591
-4% -$124K
QTS
1268
DELISTED
QTS REALTY TRUST, INC.
QTS
$3.21M 0.01%
61,298
+1,130
+2% +$58.5K
ENS icon
1269
EnerSys
ENS
$7.07B
$3.2M 0.01%
44,166
+1,579
+4% +$124K
ATO icon
1270
Atmos Energy
ATO
$28.6B
$3.2M 0.01%
38,547
+2,166
+6% +$178K
HELE icon
1271
Helen of Troy
HELE
$693M
$3.19M 0.01%
33,953
+21,483
+172% +$2M
EHC icon
1272
Encompass Health
EHC
$11B
$3.19M 0.01%
82,952
-216,535
-72% -$7.93M
GLPI icon
1273
Gaming and Leisure Properties
GLPI
$12.4B
$3.19M 0.01%
84,792
-2,401
-3% -$86K
MRVL icon
1274
Marvell Technology
MRVL
$192B
$3.19M 0.01%
192,990
+179,301
+1,310% +$2.9M
NNBR icon
1275
NN Inc
NNBR
$298M
$3.18M 0.01%
115,932
-4,463
-4% -$124K

Similar funds

Raymond James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Raymond James & Associates held 3,541 positions worth $46.3B, up 7.4% from $43.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.34B of net new capital in Q2 2017, opening 248 new positions and adding to 1,836 existing holdings. Its largest new stake was DXC Technology: 324,843 shares worth $21.6M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 9.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Novartis, an estimated $53.7M trimmed.

  • Raymond James & Associates's largest Q2 2017 buy was DXC Technology: 324,843 shares worth $21.6M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $308M increase.
  • Raymond James & Associates's biggest Q2 2017 reduction was Novartis, cutting an estimated $53.7M.
  • Raymond James & Associates fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $24.9M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $46.3B portfolio in Q2 2017.
  • Raymond James & Associates opened 248 new positions and closed 207 in Q2 2017.
  • Raymond James & Associates's portfolio value rose 7.4% quarter-over-quarter to $46.3B.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.